These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2080842)

  • 21. New antibiotics: carbapenems, monobactams and quinolones.
    Amin NM
    Am Fam Physician; 1988 Oct; 38(4):125-34. PubMed ID: 3051970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
    Rolston KV; Yadegarynia D; Kontoyiannis DP; Raad II; Ho DH
    Int J Infect Dis; 2006 May; 10(3):223-30. PubMed ID: 16439177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo studies to highlight possible illegal treatments of rabbits with carbadox and olaquindox.
    Segato G; Biancotto G; Agnoletti F; Berto G; Montesissa C; Benetti C
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2015; 32(12):1976-91. PubMed ID: 26400201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical evolution of the fluoroquinolone antimicrobial agents.
    Neu HC
    Am J Med; 1989 Dec; 87(6C):2S-9S. PubMed ID: 2557762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic Disposition and Elimination of Cyadox in Pigs, Chickens, Carp, and Rats.
    Lingli H; Ning X; Harnud S; Yuanhu P; Dongmei C; Yanfei T; Zhenli L; Zonghui Y
    J Agric Food Chem; 2015 Jun; 63(22):5557-69. PubMed ID: 25973850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative plasma and tissue pharmacokinetics and drug residue profiles of different chemotherapeutants in fowls and rabbits.
    Li T; Qiao GL; Hu GZ; Meng FD; Qiu YS; Zhang XY; Guo WX; Yie HL; Li SF; Li SY
    J Vet Pharmacol Ther; 1995 Aug; 18(4):260-73. PubMed ID: 8583539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temafloxacin: the pharmacokinetic profile of a new quinolone. A seminar-in-print.
    Clin Pharmacokinet; 1992; 22 Suppl 1():1-107. PubMed ID: 1319864
    [No Abstract]   [Full Text] [Related]  

  • 28. Kinetic interaction between theophylline and a newly developed quinolone, NY-198.
    Kuzuya T; Takagi K; Apichartpichean R; Muraoka I; Nadai M; Hasegawa T
    J Pharmacobiodyn; 1989 Jul; 12(7):405-9. PubMed ID: 2593082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of chemical structure on quinolone potency, spectrum and side effects.
    Percival A
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():1-8. PubMed ID: 1787126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A physiologically based pharmacokinetic model for the prediction of the depletion of methyl-3-quinoxaline-2-carboxylic acid, the marker residue of olaquindox, in the edible tissues of pigs.
    Yang B; Huang LL; Fang K; Wang YL; Peng DP; Liu ZL; Yuang ZH
    J Vet Pharmacol Ther; 2014 Feb; 37(1):66-82. PubMed ID: 23631588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinolones: structure-activity relationships and future predictions.
    Tillotson GS
    J Med Microbiol; 1996 May; 44(5):320-4. PubMed ID: 8636945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of quinolones in pediatrics.
    Schaad UB
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):355-60. PubMed ID: 1864297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinoxaline-2-carboxylic acid in pigs: criteria to distinguish between the illegal use of carbadox and environmental contamination.
    Hutchinson MJ; Young PB; Kennedy DG
    Food Addit Contam; 2004 Jun; 21(6):538-44. PubMed ID: 15204531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Statistical evaluation of residue data for the assessment of predicted values (half-life, withdrawal time) as an example of toltrazuril and enrofloxacin in trout].
    Brinkman B; Helfrich HP; Büning-Pfaue H
    Z Lebensm Unters Forsch; 1991 Apr; 192(4):328-34. PubMed ID: 2058309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Photophysical evaluation of photosensitization by various quinolones].
    Vermeersch G; Filali A; Marko J; Catteau JP; Couture A
    J Pharm Belg; 1990; 45(5):299-305. PubMed ID: 1964964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic aspects of newer quinolones.
    Uematsu T; Nakashima M
    Prog Drug Res; 1992; 38():39-55. PubMed ID: 1609117
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of Mequindox and Its Marker Residue 1,4-Bisdesoxymequindox in Swine Following Multiple Oral Gavage and Intramuscular Administration: An Experimental Study Coupled with Population Physiologically Based Pharmacokinetic Modeling.
    Zeng D; Lin Z; Fang B; Li M; Gehring R; Riviere JE; Zeng Z
    J Agric Food Chem; 2017 Jul; 65(28):5768-5777. PubMed ID: 28640606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Physiologic model of NY-198 pharmacokinetics using a new method of determining tissue/blood distribution coefficient].
    Manuĭlov KK
    Antibiot Khimioter; 1990 Jul; 35(7):25-7. PubMed ID: 2285337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intracranial hypertension in a newborn treated with quinolone].
    Bedu A; Naar I; Farnoux C; Brisse H; Le Huidoux P; Aujard Y
    Presse Med; 1998 Jun; 27(23):1140-2. PubMed ID: 9767795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic disposition of quinolones in human body fluids and tissues.
    Sörgel F; Jaehde U; Naber K; Stephan U
    Clin Pharmacokinet; 1989; 16 Suppl 1():5-24. PubMed ID: 2653696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.